Sanofi has appointed Belén Garijo as chief executive officer. She will take up her duties at the end of the Group's Annual General Meeting on April 29, 2026. The Board will also propose to the shareholder vote the candidacy of Belén Garijo as a director of the group. Garijo will bring an increased rigor to the implementation of Sanofi's strategy and accelerate the preparation of the group's future. Her priority will be to strengthen the productivity, governance, and innovation capacity of R&D. Press release. 

Astoriom expanded its sample management capabilities in the U.S. with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom's footprint in North America, strengthening its presence in high-growth regions for biopharmaceutical, biotechnology, and medical technology innovation. Press release. 

Flatiron Health announced their first Panoramic datasets in the U.K. and Germany for patients with prostate cancer. Globally, prostate cancer affects nearly 1.5 million patients annually and has a rapidly evolving treatment landscape, yet real-world evidence remains limited and infeasible to study across international borders. Press release. 

The University of Cincinnati (UC) and UC Health have launched the UC/UC Health Addiction Center (UCAC), a multidisciplinary initiative designed to unite research with clinical and educational expertise to improve addiction prevention and treatment outcomes in the Greater Cincinnati community and beyond. UC College of Medicine and UC Health will invest approximately $2 million over the next five years to support administrative efforts, research, clinical improvement initiatives, and fellowship programs. UCAC builds on the success of the Center for Addiction Research, leveraging the collaborative efforts of over 30 faculty members from five colleges and 12 departments. It is positioned to accelerate addiction science through pilot research funding, expanding evidence-based clinical care, enhancing addiction education and promoting community engagement. Press release. 

Clymb Clinical has launched the Clymbr Hub, the company’s new unified platform for end-to-end SAP to CSR automation. The Clymbr Hub brings together Clymb's full suite of automation and AI solutions, including TFL Designer, TFL Code Generators, and TFL Viewer, into a single integrated workspace. Press release. 

ObvioHealth, Oracle Health, and Life Sciences announced that ObvioGo is now directly integrated with Oracle Health and Life Sciences Clinical One Data Collection to help organizations support decentralized and hybrid clinical trials at scale. This new direct integration enables sponsors and CROs to deploy participant-facing trial technologies configured and delivered through ObvioGo as part of a comprehensive, unified clinical trial system. By bringing these capabilities together, organizations can limit reliance on multiple third-party solutions while maintaining consistency, oversight, and scalability across global studies. Press release. 

Evinova announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of the agreement, Bristol Myers Squibb will deploy the Cost Optimizer module of Evinova’s Study Designer across the company’s global portfolio, harnessing advanced AI to improve insight-driven decision making, identify productivity opportunities, and unlock more efficient trial designs that accelerate innovation and improve experience for sites and patients. Press release.